Physician profile
Joel Munoz
NPI 1952032971
$1,877.00
in general payments reported to CMS, 2019-2025
7 companies · $254 in 2025
The $254 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $46.16 · 2024: $1,577 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $990 · Food and Beverage: $887.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $989.63 |
| Food and Beverage | $887.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,550.43 | 2023-2025 | Precision 1, Total30, Dailies Total1 |
| Sun Pharmaceutical Industries INC. | $125.00 | 2025 | |
| Rxsight INC | $91.56 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Bausch & Lomb Americas INC. | $53.17 | 2024-2025 | Infuse, Miebo |
| Johnson & Johnson Vision Care, INC. | $23.88 | 2025 | |
| Coopervision INC. | $17.23 | 2024 | Myday Contact Lens |
| Oyster Point Pharma, INC. | $15.73 | 2024 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Munoz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.